Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05498870 · ClinicalTrials.gov registry record · Phase 4

iPACK for Post-op Pain Following ACL Reconstruction

A Phase 4 study, sponsored by Medical University of South Carolina.

Completed
Registry status
Phase 4
Development phase
82
Enrollment target

NCT05498870 is a Phase 4 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 82 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05498870, a Phase 4 study, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
Phase 4
Development phase
82 participants
Enrollment target

Study Summary

This study will consist of patients 12 years and older undergoing ACL reconstruction using a quadriceps or bone-patella tendon bone (BTB) graft. The patients will be randomized to adductor canal block alone, or adductor canal block + iPACK block. The primary goal will be to determine the differences in postoperative pain during the first 72 hours when comparing the two groups. Secondary outcomes will include opioid utilization during the first 72 hours postoperatively and range of motion including terminal knee extension at postoperative follow-up visits.

Interventions

  • DRUG Adductor Canal Block (ACB) Only
  • DRUG Adductor Canal Block (ACB) + iPACK Block

Trial Details

FieldValue
Enrollment Target 82 participants
Start Date 2022-08-25
Est. Completion 2023-08-14
Phase Phase 4

What the Registry Record Tells You About NCT05498870

The ClinicalTrials.gov registry entry for NCT05498870 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Adductor Canal Block (ACB) Only is the first listed.

NCT05498870 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05498870 about?

NCT05498870 is a clinical study titled "iPACK for Post-op Pain Following ACL Reconstruction". This study will consist of patients 12 years and older undergoing ACL reconstruction using a quadriceps or bone-patella tendon bone (BTB) graft. The patients will be randomized to adductor canal block alone, or adductor canal block + iPACK block. The primary goal will be to determine the differences...

What is the current status of trial NCT05498870?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 82 participants. The study started on 2022-08-25. Estimated completion is 2023-08-14.

What interventions are being tested in trial NCT05498870?

The interventions under investigation include: Adductor Canal Block (ACB) Only (DRUG), Adductor Canal Block (ACB) + iPACK Block (DRUG).

Who is sponsoring clinical trial NCT05498870?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.